Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate
PLOS One · 2025
DOI: 10.1371/journal.pone.0324803 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jes-Rite Michaels und 5 weiteren Autor:innen. Beteiligte Einrichtung: Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, United S…. Hauptthemen laut MEDLINE: Cleft Palate, Receptor, Transforming Growth Factor-beta Type II, Micrognathism, Receptors, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Cleft lip and cleft palate are among the most common congenital anomalies and are the result of incomplete fusion of embryonic craniofacial processes or palatal shelves, respectively. We know that genetics play a large role in these anomalies but the list of known causal genes is far from complete. As part of a larger sequencing effort of patients with congenital craniofacial anomalies, we identified a rare candidate variant in transforming growth factor beta receptor 2 ( TGFBR2 ). This variant alters a highly conserved amino acid and is predicted to be pathogenic by a number of metrics. The family history and population genetics suggest that this specific variant would be incompletely penetrant, but this gene has been convincingly implicated in craniofacial development. In order to test the hypothesis this might be a causal variant, we used genome editing to create the orthologous variant in a new mouse model. Surprisingly, Tgfbr2 V387M mice did not exhibit craniofacial anomalies or have reduced survival, suggesting Tgfbr2 V387M is not a causal variant for cleft palate/ micrognathia. The discrepancy between in silico predictions and mouse phenotypes highlights the complexity of translating human genetic findings to mouse models. We expect these findings will aid in interpretation of future variants seen in TGFBR2 from ongoing sequencing of patients with congenital craniofacial anomalies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
- Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America.
- Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
- Department of Pediatrics, School of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
ORCID-Profile: Ammar Husami, Rolf W Stottmann
Förderung
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Michaels, J. R., Iyyanar, P. P. R., Husami, A., Vontell, A. M., Brugmann, S. A., & Stottmann, R. W. (2025). Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate. PLOS One. https://doi.org/10.1371/journal.pone.0324803
Vancouver
Michaels JR, Iyyanar PPR, Husami A, Vontell AM, Brugmann SA, Stottmann RW. Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate. PLOS One. 2025. doi:10.1371/journal.pone.0324803
BibTeX
@article{Michaels2025,
author = {Michaels, Jes-Rite and Iyyanar, Paul P R and Husami, Ammar and Vontell, Andrew M and Brugmann, Samantha A and Stottmann, Rolf W},
title = {Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324803}
}
EUVIMED